Method for transcription-degradation dual regulation for protein by antibiotic
AssigneeJapan Science and Technology Agency
InventorYoshihiro Miwa
Life of this patent
Estimating the term…
Abstract
The present invention provides an expression vector, containing expressibly (a) a polynucleotide encoding a fusion protein of a mutant of a repressor protein, which binds to an antibiotic, and a target protein, and (b) a polynucleotide encoding a protein controlling the transcription of the polynucleotide in (a), the transcription of the polynucleotide in (a) and the degradation of said fusion protein, which is the expression product of the polynucleotide in (a), being controlled inside a cell by the presence or absence of an antibiotic inside the cell.
Claims28
A gene expression control composition for controlling, using a site-specific recombination enzyme, the expression of a target gene inside a cell by the presence or absence of an antibiotic in the cell into which an expression vector containing expressibly the target gene between and/or downstream of recombination sequences has been introduced, comprising:
- (a) an expression vector containing expressibly a polynucleotide encoding a fusion protein of a mutant of a repressor protein, which binds to an antibiotic, and a recombination enzyme, and
- (b) an expression vector containing expressibly a polynucleotide encoding a protein for controlling the transcription of the polynucleotide in (a).
A gene expression control kit for controlling, using a site-specific recombination enzyme, the expression of a target gene inside a cell by the presence or absence of an antibiotic in the cell into which an expression vector containing expressibly the target gene between and/or downstream of recombination sequences has been introduced, comprising
- (a) an expression vector containing expressibly a polynucleotide encoding a fusion protein of a mutant of a repressor protein, which binds to an antibiotic, and a recombination enzyme, and
- (b) an expression vector containing expressibly a polynucleotide encoding a protein for controlling the transcription of the polynucleotide in (a).
A gene expression control system for controlling, using a site-specific recombination enzyme, the expression of a target gene inside a cell by the presence or absence of an antibiotic, comprising
- (a) a cell
- (b) an expression vector that is introduced into the interior of said cell, and contains expressibly a polynucleotide encoding a fusion protein of a mutant of a repressor protein, which binds to an antibiotic, and a recombination enzyme,
- (c) an expression vector that is introduced into the interior of said cell, and contains expressibly a polynucleotide encoding a protein for controlling the transcription of the polynucleotide in (b),
- (d) an expression vector that is introduced into the interior of said cell, and contains expressibly a target gene between and/or downstream of recombination sequences, and
- (e) an antibiotic to be introduced into the interior of said cell,
- the transcription of the polynucleotide in (b) and the degradation of said fusion protein, which is the expression product of the polynucleotide in (b), being controlled inside the cell by the presence or absence of the antibiotic, and the expression of said target gene being controlled by the expressed amount of said fusion protein.
A gene expression control method for controlling, using a site-specific recombination enzyme, the expression of a target gene inside a cell by the presence or absence of an antibiotic, comprising the step of expressing under the presence or under the absence of an antibiotic inside said cell,
- (a) an expression vector containing expressibly a polynucleotide encoding a fusion protein of a mutant of a repressor protein, which binds to an antibiotic, and a recombination enzyme,
- (b) an expression vector containing expressibly a polynucleotide encoding a protein for controlling the transcription of the polynucleotide in (a), and
- (c) an expression vector containing expressibly a target gene between and/or downstream of recombination sequences.
Dependencies are inferred from the claim text.